Sponsor & Exhibit

Conference Sponsorships

Technology Showcases
Present your technology, brand your company and generate sales leads with a corporate sponsorship (includes a 10-15 minute technology talk).

Luncheon Technology Workshops
Present your technology during a 30-minute talk, over Fairmont’s fine cuisine, and walk away with pre-qualified leads.

User Group Meetings
Co-locate your company’s user group meeting with HCA. This unique opportunity allows you to design your own 5-hour program, invite your top customers and prospects, and build a “community” around your technology. Only a few opportunities remain.

Focus Groups
Sponsoring a “topic-specific” focus group allows you to get face-to-face with your target audience and share your expertise.

Additional Opportunities:
• Badge Lanyards
• Conference Tote Bags
• Travel Coffee Mugs
• Conference Padfolios

Don’t miss the opportunity for recognition during the conference and long after.
High-quality promotional items with your corporate logo will be distributed
to every delegate.

For more information, please contact Carol Dinerstein
at 781-972-5471 or dinerstein@healthtech.com.

---

Corporate Biographies

Executive Sponsor:

Cellomics, Inc. is automating drug discovery through a unique, cell-based assay platform that addresses the needs of Drug Discovery and Systems Biology groups by offering complete systems for High Content Screening (HCS). The platform includes HCS instrumentation (both fixed end-point and kinetic systems), informatics, cellular image analysis software (BioApplications), fluorescent reagents, kits, cell lines, and multiparametric assays. When applied to early drug discovery, this platform is proving to reduce the ‘idea-to-discovery’ cycle time in drug discovery, while increasing the probability of the therapeutic success of leads as well as enhancing throughput in systems biology and basic research.

Premier Sponsor:

GE Healthcare (formerly Amersham Biosciences) offers products and services dedicated to the discovery and development of safe and effective drugs. Imaging instruments such as IN Cell Analyzer 1000 and 3000, reagents, software, and informatics systems utilized in cellular assays and High-Content Analysis will be featured at the Cambridge Healthtech Institute's HCA 2005 conference.

Corporate Sponsors:

BD Biosciences is a segment of BD (Becton, Dickinson and Company) and is built on the BD 100+-year foundation of quality, reliability, and commitment to customers and business partners around the world. As one of the world’s largest businesses serving the life sciences, BD Biosciences provides a comprehensive portfolio of reagents, systems, and technical expertise, offering solutions to life scientists and accelerating the pace of biomedical discovery and diagnosis

BioImage A/S is an early stage drug discovery company focusing on cell-based pathway screening for the identification of new small molecule therapeutics. BioImage's Redistribution® technology monitors intracellular protein translocation as the primary assay readout, using Green Fluorescent Protein (GFP) tagged target. In addition to running internal discovery projects, BioImage sells assays, performs pathway profiling, and out-licenses Redistribution®.

Definiens is a leading provider of high-content image analysis solutions. Based on Definiens Cognition Network Technology®, a fundamental technology which models human thought, Definiens products enable the extraction of objects of interest from biomedical images. Main applications are in drug research and other biopharmaceutical processes. Definiens more than 100 customers in the field of life sciences are companies such as Altana, Aventis, Intervet, Merck, Novartis, and Novo Nordisk as well as Academia & Research Institutions such as NGFN and NIH. Founded in 1994 by Nobel Prize Laureate Prof. Dr. Gerd Binnig, Definiens today has 40 employees and is based in Munich, Germany. For further information regarding the company and its products please visit www.definiens.com.

Evotec Technologies GmbH (ET) is an innovative technology provider for complex life sciences applications. ET’s current portfolio comprises a uHTS screening platform EVOscreen®, high content analysis plate readers for biochemical assays (Clarina™ II) and cellular assays (Opera™) and Elektra, a platform using chipbased cellprocessors for image activated cell sorting as well as consumables and reagents. ET’s solutions are based on its broad patent portfolio, scientific excellence- from drug discovery to systems biology - and technical know-how.

IBM Healthcare and Life Sciences brings together IBM resources, including information technology, deep industry insights, and research expertise, to help clients develop and deliver safer, more affordable and more effective diagnostics, drugs and medical care.

Molecular Devices is a leading supplier of high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. The company's high content imaging systems, image analysis software and database management solutions provide a comprehensive solution for automated cellular image acquisition, segmentation, data reduction and management.

Vitra Bioscience’s mission is to deliver technologies for establishing predictive toxicity and efficacy profiling of new drugs to reduce failures in the clinic. The CellCard System enables scientists to evaluate potential new drug candidates rapidly and thoroughly so decision-critical information can be obtained much earlier in the drug discovery process. Specifically, Vitra Bioscience’s technology improves clinical trial outcomes. By facilitating parallel functional testing of focused compound libraries, potency and selectivity can be tested simultaneously. Predictive toxicity and efficacy profiles can then be generated in less time, so decision critical data is available earlier. Pathway focused target screening is also enabled by examining multiple cell types on complex targets. Additionally, the CellCard System is optimal for testing primary cells, thus providing more physiologically relevant biological outcomes.

Exhibitors (as of December 2004)

Company/Booth # Accelrys 11 Applied Precision, LLC  6 Arcturus    207 BD Biosciences  18 Beckman Coulter  19 BioImage A/S 15 BioImagene/Scimagix 20 BioSource International, Inc. 17 Biolog, Inc.   22 Cellomics   1,2 Definiens AG  13 EMC Corporation  3 Evotec Technologies  9 GE Healthcare  24 Molecular Devices   4 Olympus America  10 Promega Corporation  5 TEF Labs   16 Vitra Bioscience   14 Reserved                               12

For more information, please contact Carol Dinerstein
at 781-972-5471 or dinerstein@healthtech.com.